Yi Ren

Title: Yi Ren: Innovator in Pharmaceutical Chemistry

Introduction

Yi Ren is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystal forms of drugs. His work focuses on enhancing the stability and quality of pharmaceutical compounds.

Latest Patents

Yi Ren holds a patent for the "Crystal form of Treprostinil sodium salt and preparation method therefor." This patent discloses a new crystal form of treprostinil sodium salt, including five and a half hydrates and some dehydrated crystal forms. The new crystal form exhibits improved stability and hygroscopicity, making it suitable for storage, loading, and transportation. This innovation ensures that the quality of the treprostinil crude drug remains stable, thereby guaranteeing the controllable quality of subsequent preparation products.

Career Highlights

Throughout his career, Yi Ren has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Shanghai Forefront Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Yi Ren has collaborated with several professionals in his field, including Wei Zhang and Junli Chen. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical chemistry.

Conclusion

Yi Ren's contributions to the field of pharmaceutical chemistry, particularly through his patent on treprostinil sodium salt, highlight his role as an innovator. His work not only advances drug stability but also enhances the quality of pharmaceutical products.